Stock Research for TNXP

TNXP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TNXP Stock Chart & Research Data

The TNXP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TNXP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TNXP Due diligence Resources & Stock Charts

The TNXP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TNXP Detailed Price Forecast - CNN Money CNN View TNXP Detailed Summary - Google Finance
Yahoo View TNXP Detailed Summary - Yahoo! Finance Zacks View TNXP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TNXP Trends & Analysis - Trade-Ideas Barrons View TNXP Major Holders - Barrons
NASDAQ View TNXP Call Transcripts - NASDAQ Seeking View TNXP Breaking News & Analysis - Seeking Alpha
Spotlight View TNXP Annual Report - CompanySpotlight.com OTC Report View TNXP OTC Short Report - OTCShortReport.com
TradeKing View TNXP Fundamentals - TradeKing Charts View TNXP SEC Filings - Bar Chart
WSJ View Historical Prices for TNXP - The WSJ Morningstar View Performance/Total Return for TNXP - Morningstar
MarketWatch View the Analyst Estimates for TNXP - MarketWatch CNBC View the Earnings History for TNXP - CNBC
StockMarketWatch View the TNXP Earnings - StockMarketWatch MacroAxis View TNXP Buy or Sell Recommendations - MacroAxis
Bullish View the TNXP Bullish Patterns - American Bulls Short Pains View TNXP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TNXP Stock Mentions - StockTwits PennyStocks View TNXP Stock Mentions - PennyStockTweets
Twitter View TNXP Stock Mentions - Twitter Invest Hub View TNXP Investment Forum News - Investor Hub
Yahoo View TNXP Stock Mentions - Yahoo! Message Board Seeking Alpha View TNXP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TNXP - SECform4.com Insider Cow View Insider Transactions for TNXP - Insider Cow
CNBC View TNXP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TNXP - OTC Markets
Yahoo View Insider Transactions for TNXP - Yahoo! Finance NASDAQ View Institutional Holdings for TNXP - NASDAQ


Stock Charts

FinViz View TNXP Stock Insight & Charts - FinViz.com StockCharts View TNXP Investment Charts - StockCharts.com
BarChart View TNXP Stock Overview & Charts - BarChart Trading View View TNXP User Generated Charts - Trading View




Latest Financial News for TNXP


3 Biotech Stocks to Dump Before They Go to Zero
Posted on Tuesday April 09, 2024

It is not a bad idea to hunt for biotech stocks to sell. Such stocks have earned a bad reputation among investors, and for good reason. Most biotech companies fail, as their success often hinges on receiving regulatory approval for their products. It is an extremely high-risk sector to invest in. For every promising biotech company that successfully navigates clinical trials and generates multibagger returns, there are 99 others that either fail outright or struggle to deliver any gains at all.


Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Posted on Monday April 01, 2024

Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya™ for fibromyalgia for NDA submission second half of 2024; pre-NDA meeting with FDA scheduled for second quarter 2024 Commercial planning underway, including go-to-market, supply chain and manufacturing strategies, for U.S. launch of Tonmya, a potential new first-line, centrally-acting, non-opioid analgesic for the management of fibromyalgia CHATHAM, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Tonix


Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Posted on Thursday March 28, 2024

CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase agreement with existing healthcare focused institutional investors of the Company for the purchase and sale of 14,666,666 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 14,666,666 shares of common stock in a reg


Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Posted on Monday March 25, 2024

TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating Prader Willi syndrome is the most common genetic cause of life-threatening childhood obesity CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the U.S. Food and Drug Adm


Stock Market & Investing Books

Enter a stock symbol to view the stock details.